Patients Don't Remember What Their Doctors Tell Them

Publication
Article
OncologyONCOLOGY Vol 11 No 5
Volume 11
Issue 5

Mayo Clinic study of patient-physician communication found that patients frequently do not remember what their doctor tells them.

Mayo Clinic study of patient-physician communication found that patientsfrequently do not remember what their doctor tells them.

The study, reported in the December issue of Mayo Clinic Proceedings,focused on the results of general medical examinations given to 566 communitypatients. Researchers collected information from both patients and physiciansabout health problems and cardiac risk factors uncovered in the examinations.They found that patients, surveyed at home after the examination, did notmention 68% of health problems diagnosed by their physician, including54% of their most important diagnosed health problems. Some of the mostfrequently diagnosed health problems not reported by patients included:hypothyroidism, colorectal polyps, obesity, osteoarthritis, and tobaccoabuse.

Study author Dr. Sidna Scheitel believes that the low level of agreementbetween physician and patients is due to a number of factors--misunderstandingof medical terminology used by doctors; "selective listening";and denial of the presence of health issues, such as obesity and tobaccouse. Also, patients and physicians may differ in their perception of theimportance of a health problem.

The survey found that patients who had received a new diagnosis or diagnosisof a major health problem and patients who traveled a considerable distancefor their care were most likely to remember and follow what their doctorhad discussed with them.

Dr. Scheitel says the study suggests that doctors should consider givingproblem lists or summary letters to patients to improve and reinforce thecommunication and management of health problems.

Recent Videos
7 experts are featured in this series.
Gedatolisib-based triplet regimens may be effective among patients with prior endocrine resistance or rapid progression following frontline therapy.
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Receiving information regarding tumor-associated antigens or mutational statuses from biopsies may help treatment selection in GI malignancies.
An easy-to-access database allows one to see a patient’s cancer stage, prior treatment, and survival outcomes in a single place.
Related Content